HD2A Research Adoption Support Center (RASC)
HD2A 研究采用支持中心 (RASC)
基本信息
- 批准号:10708980
- 负责人:
- 金额:$ 312.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptionAttitudeAwarenessCase StudyCatalogsCollaborationsCommunitiesComplexConsensusDataDevelopmentDimensionsDissemination and ImplementationEconomicsEnsureEpidemicEquityEvaluationEvidence based interventionEvidence based practiceFacultyGoalsHarm ReductionHealthHumanInterventionIntervention StudiesInvestmentsKnowledgeLeadershipLearningLifeMeasurementMeasuresMethodologyMethodsModelingMonitorNational Institute of Drug AbuseOpiate AddictionOpioidOutcomePainPain managementPersonsPoliciesPreventionPrevention strategyPublic HealthPublicationsQualifyingRecordsResearchResearch DesignResearch PersonnelResearch Project GrantsResourcesScientistServicesSiteSpecific qualifier valueStandardizationStimulantSubstance Use DisorderSystemTechnical ExpertiseTerminologyTheoretical modelThinkingTranslatingTranslational ResearchUnited States National Institutes of Healthaddictioncommunity livingdata harmonizationdata infrastructuredesigndissemination scienceevidence baseexperienceformative assessmenthealth care availabilityimplementation evaluationimplementation researchimplementation scienceimplementation strategyimplementation studyimplementation toolimprovedinnovationknowledge baseonline resourceopioid epidemicopioid mortalityopioid use disorderoverdose deathoverdose preventionpreventprogram disseminationprogramsprovider interventionreal world applicationresearch studyresource guidesresponseservice deliverysocial capitalsocial stigmastemsubstance usesubstance use preventionsymposiumtranslational barrier
项目摘要
OVERALL: PROJECT SUMMARY/ABSTRACT
In response to the National Institutes of Health RFA-DA-22-050, we herein propose a HEAL Data2Action
Research Adoption Support Center (RASC). The main purpose of the RASC is to stem the tide of overdose
death in the US by leading a scientifically-driven support endeavor designed to effectively translate evidence-
based interventions for substance use disorders and pain. Presently, overdose death escalates. Dissemination
and implementation (D&I) science is the methodological bridge to both the scientific and public health gaps.
Yet D&I science is understudied and underutilized in response to the opioid epidemic. Emblematic of
heightened awareness for D&I scientific potential, the HEAL D2A Program will be launched. The program
features 10-12 Innovation Projects, and, in addition to the RASC, two additional centers: Modeling and
Economic Resource Center and Data Infrastructure Support Center. The RASC will optimize and elevate the
D&I capability of the overall HD2A program. In this OVERALL component, we document how the RASC is
organized into four synergistic and dynamic cores: Administrative, Substance Use Implementation Support
Core, Pain Implementation Support Core, and a Research & Evaluation Core. Three overarching specific aims
are strategically ordered across the RASC and all its cores follows: To ASSESS the current state of the HD2A
Innovation Projects on D&I research capability, and develop an empirically-based catalog of evidence-based
and emerging interventions for substance use disorders and pain; to ASSIST on how Innovation Projects can
improve D&I methods and measures through on demand technical assistance and the use of an innovative
Implementation Support Plan, and to develop SUD and Pain Intervention D&I Resource Guides; and lastly, to
ADVANCE the HD2A Innovation Projects toward greater potential for scalability and sustainment. The RASC is
led by 4 MPIs with demonstrated track records of D&I research and practice in the fields of substance use and
pain interventions: McGovern (Stanford), S. Becker (Brown), W. Becker (Yale) and Brown (Northwestern). The
MPIs are joined by complementary expert core co-directors, and have assembled an unmatched roster of
highly-qualified leaders in these fields—carefully selected, organized and ready to provide the necessary
implementation support across the HD2A program. This RASC meets all the specified requirements as
outlined in the RFA. What distinguishes this RASC is our bold ambition to enhance not only the D&I capability
of the HEAL HD2A program, but to influence the field far beyond the confines of the HD2A initiative. We intend
to elevate the D&I paradigm of substance use and pain intervention research, and thereby ensure ubiquitous
and equitable access to proven interventions by the people and communities who need them the most.
总体:项目总结/摘要
作为对美国国立卫生研究院RFA-DA-22-050的响应,我们在此提出了一个HEAL Data 2Action
研究采用支持中心(RASC)。RASC的主要目的是阻止药物过量的浪潮
通过领导一项科学驱动的支持奋进,旨在有效地转化证据,
药物使用障碍和疼痛的干预措施。目前,药物过量死亡率上升。传播
D&I科学是科学和公共卫生差距的方法桥梁。
然而,D&I科学在应对阿片类药物流行病方面没有得到充分研究和利用。的象征
为了提高对D&I科学潜力的认识,将启动HEAL D2 A计划。程序
拥有10-12个创新项目,除了RASC,还有两个额外的中心:建模和
经济资源中心和数据基础设施支持中心。RASC将优化和提升
整个HD 2A计划的D&I能力。在这个整体组件中,我们记录了RASC是如何
组织成四个协同和动态的核心:行政、物质使用执行支助
核心、Pain实施支持核心和研究与评估核心。三大具体目标
在整个RASC中按策略排序,其所有核心如下:
D&I研究能力的创新项目,并制定基于证据的
以及药物使用障碍和疼痛的新兴干预措施;协助创新项目如何
通过按需提供技术援助和采用创新的
实施支持计划,并制定SUD和疼痛干预D&I资源指南;最后,
推进HD 2A创新项目,以实现更大的可扩展性和可持续性潜力。RASC是
由4名在药物使用领域具有D&I研究和实践记录的MPI领导,
疼痛干预:McGovern(斯坦福大学),S. Becker(Brown),W.贝克尔(耶鲁)和布朗(西北)。的
MPI由互补的专家核心共同董事加入,并汇集了一个无与伦比的名册,
这些领域的高素质领导者-精心挑选,组织,并准备提供必要的
在整个HD 2A计划中提供实施支持。本RASC符合所有规定要求,
在RFA中列出。这个RASC的与众不同之处在于我们大胆的雄心,不仅要提高D&I能力,
HEAL HD 2A计划的一部分,但影响远远超出HD 2A计划的范围。我们打算
提升药物使用和疼痛干预研究的D&I范式,从而确保无处不在
以及最需要的人民和社区公平地获得经过验证的干预措施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM C BECKER其他文献
WILLIAM C BECKER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM C BECKER', 18)}}的其他基金
Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy - Yale Resource Center (MIRHIQL-YRC)
多层次干预措施可减少长期阿片类药物治疗患者的伤害并提高其生活质量 - 耶鲁大学资源中心 (MIRHIQL-YRC)
- 批准号:
10722768 - 财政年份:2023
- 资助金额:
$ 312.38万 - 项目类别:
Role of Non-pharmacological Pain Treatments in Safe and Effective Opioid Tapering in Chronic Pain
非药物疼痛治疗在安全有效地逐渐减少慢性疼痛中阿片类药物的作用
- 批准号:
10620195 - 财政年份:2022
- 资助金额:
$ 312.38万 - 项目类别:
HD2A RASC - Pain Implementation Support Core
HD2A RASC - 疼痛实施支持核心
- 批准号:
10596438 - 财政年份:2022
- 资助金额:
$ 312.38万 - 项目类别:
HD2A Research Adoption Support Center (RASC)
HD2A 研究采用支持中心 (RASC)
- 批准号:
10596435 - 财政年份:2022
- 资助金额:
$ 312.38万 - 项目类别:
HD2A RASC - Pain Implementation Support Core
HD2A RASC - 疼痛实施支持核心
- 批准号:
10708984 - 财政年份:2022
- 资助金额:
$ 312.38万 - 项目类别:
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers
HEAL 计划:慢性疼痛和 OUD 整体康复综合管理 (IMPOWR):研究中心
- 批准号:
10876682 - 财政年份:2021
- 资助金额:
$ 312.38万 - 项目类别:
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers
HEAL 计划:慢性疼痛和 OUD 整体康复综合管理 (IMPOWR):研究中心
- 批准号:
10652027 - 财政年份:2021
- 资助金额:
$ 312.38万 - 项目类别:
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers
HEAL 计划:慢性疼痛和 OUD 整体康复综合管理 (IMPOWR):研究中心
- 批准号:
10378910 - 财政年份:2021
- 资助金额:
$ 312.38万 - 项目类别:
Implementation of a Pragmatic Trial of Whole Health Team vs. Primary Care Group Education to Promote Non-Pharmacological Strategies to Improve Pain, Function and Quality of Life in Veterans
实施整体健康团队与初级保健团体教育的务实试验,以促进非药物策略,改善退伍军人的疼痛、功能和生活质量
- 批准号:
10090568 - 财政年份:2020
- 资助金额:
$ 312.38万 - 项目类别:
Implementation of a Pragmatic Trial of Whole Health Team vs. Primary Care Group Education to Promote Non-Pharmacological Strategies to Improve Pain, Function and Quality of Life in Veterans
实施整体健康团队与初级保健团体教育的务实试验,以促进非药物策略,改善退伍军人的疼痛、功能和生活质量
- 批准号:
10533361 - 财政年份:2020
- 资助金额:
$ 312.38万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 312.38万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 312.38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 312.38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 312.38万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 312.38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 312.38万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 312.38万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 312.38万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 312.38万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 312.38万 - 项目类别:
Standard Grant